MAD2L1 and neuroblastoma: Network‐based analysis further refined this set to 11 hub prognostic biomarkers for NB: AURKA, BLM, BRCA1, BRCA2, CCNA2, CHEK1, E2F1, MAD2L1, PLK1, RAD51, and RFC3.